Johannes Vermehren

8PUBLICATIONS
7CO-AUTHORS
Nutritional epidemiologyCardiovascular medicine and haematology not elsewhere classifiedNanotoxicology, health and safetyHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2018
Risk factors for early and late procedure-related adverse events in percutaneous endoscopic gastrostomy: A single center, retrospective study.

Jan Peveling-Oberhag, Imad Osman, Dirk Walter

|Jun 08, 2018
Editorial: genotype 3 HCV-who still needs ribavirin in a pan-genotypic era? Authors' reply.

J von Felden, J Vermehren, J Schulze Zur Wiesch

|Jun 08, 2018
Letter: adoption of uniform nomenclature is crucial for estimating the true risk of HBV reactivation in patients treated with direct-acting antivirals for hepatitis C.

M M Mücke, V T Mücke, J Vermehren

|Apr 12, 2018
Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.

L Kuhnhenn, B Jiang, A Kubesch

|Mar 15, 2018
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection.

J von Felden, J Vermehren, P Ingiliz

|Oct 13, 2017
Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors' reply.

M M Mücke, V T Mücke, J Vermehren

Pageof 2

Frequent Collaborators

2 joint publications

K-H Peiffer

2 joint publications

J von Felden

2 joint publications

Viola Knop

1 joint publications

F Finkelmeier